January is Alzheimer’s Awareness Month. Dr. Cheryl Wellington, a Professor in the Department of Pathology and Laboratory Medicine, has devoted her career to understanding the genetic and environmental risk factors that affect dementia. Her discovery of the role that apolipoprotein (ApoE) – a cholesterol carrier in the brain – plays in Alzheimer’s is internationally recognized and has offered us a better understanding of the disease.
You are hereNews & Events
The biochemical reactions that cause Alzheimer’s disease could be set in motion in the womb or just after birth if the fetus or newborn does not get enough Vitamin A, according to new research from the Djavad Mowafaghian Centre for Brain Health at the University of British Columbia.
Although it has long been known that Alzheimer’s disease unfolds in a person’s brain decades before symptoms appear, this is the first time the roots of the disease have been traced back to infancy or pre-natal development.
A new physician-engagement initiative is coming to UBC Hospital and the Djavad Mowafaghian Centre for Brain Health.
The initiative’s goal is to involve physicians working in acute care facilities as true partners in the healthcare decision-making process, and help generate improvements that will make our future BC healthcare system sustainable. Without involving physicians, achieving better patient care, and better community health at the lowest cost possible will remain elusive goals.
On the first floor of the Djavad Mowafaghian Centre for Brain Health, a massive, two decade-long project has been quietly underway for the past three years. The Vancouver Data Collection Site for the Canadian Longitudinal Study on Aging (CLSA) is based here, and Dr. Heather Stewart and her team are returning to the Centre to start the first follow-up after 18 months collecting data at SFU Surrey’s CLSA data collection site.
New research from Dr. Brian MacVicar’s lab has found a way to partially restore brain cell communication around areas damaged by plaques associated with Alzheimer’s disease. The findings, published this week in Nature Communications, demonstrate a possible target and a potential drug treatment to reduce damage to the brain that occurs in the early stages of Alzheimer’s disease.
Research shows that walking just ten blocks per day can have neuroprotective benefits as many as nine years later – Walk10Blocks makes it easy to take the first steps toward improved cognition and joint and cardiovascular health
New research from the Djavad Mowafaghian Centre for Brain Health finds that many online resources for preventing Alzheimer’s disease are problematic and could be steering people in the wrong direction.
In a survey of online articles about preventing Alzheimer’s disease, Centre researchers found many websites offered poor advice and one in five promoted products for sale—a clear conflict of interest.
The Canadian Institutes for Health Research (CIHR) has announced its latest grants, and 14 members of the Djavad Mowafaghian Centre for Brain Health are among the awardees.
Brian MacVicar, Professor, Department of Psychiatry and Co-Director of the Centre received the largest grant in the Faculty of Medicine from CIHR’s latest round of awards, with a Foundation Grant of $3.3 million over seven years. Dr. MacVicar’s lab will explore neuron-glia interactions in brain disease.